Kool-ex (Kool-Ex Cold Chain) is a Mumbai-based Indian cold chain logistics company that operates reefer trucks and temperature-controlled transport for pharmaceuticals and vaccines.

This Startup Deep Dive explains what Kool-ex does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Kool-ex in Brief

• What it is: Kool-ex is an Indian Cold chain logistics company based in Mumbai.
• Who it serves: businesses, institutions, consumers, learners and public-sector buyers.
• Provides temperature-controlled transport of pharmaceuticals and vaccines in India.
• Operates a fleet of reefer (refrigerated) trucks and container trucks and warehouses.
• Delivers to up-country and down-country destinations and to international airports.
• Funding: Not disclosed in public sources reviewed.

Kool-ex Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Kool-ex?

Kool-ex operates in the Cold chain logistics space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Kool-ex.

• Provides temperature-controlled transport of pharmaceuticals and vaccines in India.
• Operates a fleet of reefer (refrigerated) trucks and container trucks and warehouses.
• Delivers to up-country and down-country destinations and to international airports.
• Began carrying Serum Institute of India's Covishield vaccine on 11 January 2021.

The Origin Story of Kool-ex

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Kunal Agarwal.
• Described as a Mumbai-based cold chain logistics provider; founding year is not stated in sources read.
• Kunal Agarwal is named as co-founder and director.
• A 2020 magazine feature reportedly cites 23 years of pharma cold chain transport experience, which suggests roots in the late 1990s, but this is from a snippet only.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Cold chain logistics sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• January 2021: moved over 1.1 crore Covid-19 vaccine doses in 30 hours.
• 2021: planned three GDP/GWP-compliant pharma distribution centres near Mumbai, Delhi and Bangalore with IndoSpace, each with 42,000 pallet positions.
• 2020: reported to be expanding into warehousing and blockchain for pharma (snippet only).

Kool-ex Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Detailed round-by-round funding for Kool-ex is not disclosed in the public sources reviewed.
• Readers should check regulatory filings and company announcements for the latest position.

How Does Kool-ex Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to businesses, institutions, consumers, learners and public-sector buyers, sales cycles and contract size matter as much as headline growth.

• Asset-heavy cold chain transport fleet serving pharma shippers.
• Plans for temperature-controlled warehousing and distribution centres.

The Numbers: Kool-ex Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• Audited revenue, profit and loss figures for Kool-ex were not available in the public sources reviewed.
• Readers can check the company’s filings with the Registrar of Companies for the latest financial statements.

Market Opportunity for Kool-ex

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising digital adoption, cloud and mobile penetration, growing enterprise technology spending, government digitisation programmes and a deep pool of engineering talent. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Pharma and vaccine cold chain demand in India, boosted by Covid-19 vaccination drives.

Technology and Product at Kool-ex

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are product quality, data and integration depth, security, scalability and the speed of shipping improvements.

• Temperature-controlled reefer trucks; blockchain tracking for pharma was reportedly planned.

Team and Culture at Kool-ex

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Kunal Agarwal, co-founder and director.

Kool-ex Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Kool-ex

• Capital-intensive fleet and warehouse model.
• Concentration in pharma and vaccine shippers.
• Little public information on finances or ownership.
• Competition: low barriers to entry and well-funded rivals can compress pricing and slow growth.
• Funding risk: technology businesses often burn cash before reaching profit and depend on investor appetite.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by data protection rules under the Digital Personal Data Protection Act, sector regulators, consumer protection law and IT rules.

Kool-ex Growth Outlook: What to Watch

• Planned pharma distribution centres could extend it into warehousing.
• Key indicators: recurring revenue, customer retention, gross margin, customer acquisition cost and runway.
• Funding position: Whether Kool-ex can reach its next milestone before needing new capital.
• Regulation: Changes from data protection rules under the Digital Personal Data Protection Act, sector regulators, consumer protection law and IT rules.

Industry Context: Where Kool-ex Fits

India's technology startup ecosystem is one of the largest in the world, supported by cheap data, a large base of smartphone users, digital public infrastructure and a deep engineering talent pool. Companies now build for education, software, mobility, logistics, agriculture, defence, media and more, selling both to Indian customers and abroad.

Durable technology companies usually combine a clear customer problem with repeatable distribution and disciplined unit economics. Growth funded only by spending tends to fade, while products that customers keep using and paying for build compounding advantages.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Kool-ex

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Kool-ex.

Bull case

• A large and growing base of digital users and businesses expands the addressable market.
• Recurring revenue and strong retention can compound growth.
• Selling into global markets widens the opportunity beyond India.

Bear case

• Heavy competition can compress pricing and margins.
• Dependence on external funding can force painful cost cuts.
• Regulation or platform changes can disrupt a product quickly.

Lessons Founders and Investors Can Take from Kool-ex

Studying a company in the Cold chain logistics space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Kool-ex.

• Solving a clear, frequent customer problem matters more than adding features.
• Retention and repeat usage are better health signals than sign-ups.
• Disciplined spending extends runway and keeps options open when funding tightens.
• Distribution, not just product quality, decides who wins in crowded markets.
• Building trust through data protection and reliability is part of the product.

How to Evaluate Kool-ex as a Startup

• Customer clarity: Can Kool-ex name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Kool-ex is part of India’s growing Cold chain logistics ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. Public sources can also describe the same company in different ways, so it is worth checking dates, definitions and whether a figure refers to revenue, total income or transaction value, and whether it covers one entity or a wider group, before drawing conclusions. Small differences in rounding, currency conversion or reporting periods can also change how a figure reads. Comparing the same figure across several recent reports helps show whether it is stable or has changed over time. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Kool-ex FAQs: Frequently Asked Questions

What is Kool-ex?

Kool-ex (Kool-Ex Cold Chain) is a Mumbai-based Indian cold chain logistics company that operates reefer trucks and temperature-controlled transport for pharmaceuticals and vaccines. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Kool-ex?

Kool-ex was founded by Kunal Agarwal.

How much funding has Kool-ex raised?

No reliable total funding figure is disclosed in the public sources reviewed. Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Kool-ex make money?

Kool-ex earns revenue from its Cold chain logistics products and services sold to businesses, institutions, consumers, learners and public-sector buyers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Kool-ex?

Reported rivals include TESSOL, Crystal Logistic Cool Chain. See the competitor comparison above for how they differ.

What are the main risks for Kool-ex?

Main risks include competition: low barriers to entry and well-funded rivals can compress pricing and slow growth, funding and capital needs, competition and regulation by data protection rules under the Digital Personal Data Protection Act, sector regulators, consumer protection law and IT rules. This is educational content, not investment advice.

Related Startup Deep Dives: ClickPost — Raised $6 million Series A in April 2024 led by Inflexor Ventures and Athera Venture Partners | Supertails — FY25 revenue Rs 108.3 crore (up 68%), net loss Rs 52.5 crore; raised $30 million Series C led by Venturi Partners in Feb 2026. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.